Table 3.
Other reported past-year drug use according to whether drug use was reported on the screener.
| Among Those Reporting Any Drug Use on Screener (n = 59), % (n) | Among Those Reporting Marijuana Use on Screener (n = 56), % (n) | Among Those Not Reporting Any Drug Use on Screener (n = 9), % (n) | |
|---|---|---|---|
| Benzodiazepines (nonmedical) | 10.2 (6) | 7.1 (4) | 16.7 (2) |
| Amphetamine (nonmedical) | 13.6 (8) | 14.3 (8) | 0.0 (0) |
| Shrooms | 6.8 (4) | 7.1 (4) | 0.0 (0) |
| Poppers | 6.8 (4) | 7.1 (4) | 0.0 (0) |
| Synthetic Cannabinoids | 5.1 (3) | 5.4 (3) | 0.0 (0) |
| Synthetic Cathinones | 5.1 (3) | 5.4 (3) | 0.0 (0) |
| Novel Psychedelics | 5.1 (3) | 5.4 (3) | 0.0 (0) |
| Ketamine | 1.7 (1) | 1.8 (1) | 0.0 (0) |
| GHB | 1.7 (1) | 1.8 (1) | 0.0 (0) |
Note. A total of 68 participants completed the full survey—59 of whom reported drug use on the screener and 9 of whom did not report drug use on the screener. Past-year use of synthetic cathinones (“bath salts”), novel psychedelics, and nonmedical use of benzodiazepines was coded affirmatively based on the participant reporting use of any drug listed within that category.